Home / Tolterodine / Canada
CA ATC G04BD07 · updated 2 Nov 2026
Tolterodine shortage in Canada
Is there a Tolterodine shortage in Canada?
Yes. As of 2 Nov 2026, 7 Tolterodine products are reported short in Canada, the first since 4 Oct 2023. The company estimate for the return is 22 Jan 2027 (latest 31 Jan 2027). Main reason: manufacturing problem.
Also short in Germany, Spain, Ireland, Austria, Belgium, Norway, Sweden. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | TEVA-TOLTERODINE (60) | TEVA CANADA LIMITED | 4 Oct 2023 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TEVA-TOLTERODINE (60) | TEVA CANADA LIMITED | 4 Oct 2023 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TEVA-TOLTERODINE LA (30s 100s) | TEVA CANADA LIMITED | 27 Nov 2024 | 31 Jan 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TEVA-TOLTERODINE LA (30's & 100's) | TEVA CANADA LIMITED | 11 Dec 2024 | 31 Jan 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TEVA-TOLTERODINE LA (100) | TEVA CANADA LIMITED | 18 Dec 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | DETROL (1 x 60 BTL CA) | BGP PHARMA ULC | 30 Dec 2025 | not given | Increased demand Demand increase for the drug |
| CA | JAMP TOLTERODINE (100) | JAMP PHARMA CORPORATION | 15 Sep 2026 | 22 Jan 2027 | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.